Literature DB >> 23117190

Peptide:MHC tetramer-based enrichment of epitope-specific T cells.

Francois P Legoux1, James J Moon.   

Abstract

A basic necessity for researchers studying adaptive immunity with in vivo experimental models is an ability to identify T cells based on their T cell antigen receptor (TCR) specificity. Many indirect methods are available in which a bulk population of T cells is stimulated in vitro with a specific antigen and epitope-specific T cells are identified through the measurement of a functional response such as proliferation, cytokine production, or expression of activation markers(1). However, these methods only identify epitope-specific T cells exhibiting one of many possible functions, and they are not sensitive enough to detect epitope-specific T cells at naive precursor frequencies. A popular alternative is the TCR transgenic adoptive transfer model, in which monoclonal T cells from a TCR transgenic mouse are seeded into histocompatible hosts to create a large precursor population of epitope-specific T cells that can be easily tracked with the use of a congenic marker antibody(2,3). While powerful, this method suffers from experimental artifacts associated with the unphysiological frequency of T cells with specificity for a single epitope(4,5). Moreover, this system cannot be used to investigate the functional heterogeneity of epitope-specific T cell clones within a polyclonal population. The ideal way to study adaptive immunity should involve the direct detection of epitope-specific T cells from the endogenous T cell repertoire using a method that distinguishes TCR specificity solely by its binding to cognate peptide:MHC (pMHC) complexes. The use of pMHC tetramers and flow cytometry accomplishes this(6), but is limited to the detection of high frequency populations of epitope-specific T cells only found following antigen-induced clonal expansion. In this protocol, we describe a method that coordinates the use of pMHC tetramers and magnetic cell enrichment technology to enable detection of extremely low frequency epitope-specific T cells from mouse lymphoid tissues(3,7). With this technique, one can comprehensively track entire epitope-specific populations of endogenous T cells in mice at all stages of the immune response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23117190      PMCID: PMC3490303          DOI: 10.3791/4420

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  21 in total

1.  Naive and memory CD4+ T cell survival controlled by clonal abundance.

Authors:  Jason Hataye; James J Moon; Alexander Khoruts; Cavan Reilly; Marc K Jenkins
Journal:  Science       Date:  2006-03-02       Impact factor: 47.728

2.  Laboratory analysis of T-cell immunity.

Authors:  Keith L Knutson; Corazon dela Rosa; Mary Lenora Disis
Journal:  Front Biosci       Date:  2006-05-01

3.  The linear range for accurately quantifying antigen-specific T-cell frequencies by tetramer staining during natural immune responses.

Authors:  Shirley G K Seah; Robyn M Sutherland; Nicole L La Gruta; Lorena E Brown; Emma M Carrington; Gabrielle T Belz; Jamie L Brady; Stephen J Turner; Yifan Zhan; Andrew M Lew
Journal:  Eur J Immunol       Date:  2011-04-11       Impact factor: 5.532

Review 4.  Interrogating the repertoire: broadening the scope of peptide-MHC multimer analysis.

Authors:  Mark M Davis; John D Altman; Evan W Newell
Journal:  Nat Rev Immunol       Date:  2011-07-15       Impact factor: 53.106

5.  MHC class II-specific T cells can develop in the CD8 lineage when CD4 is absent.

Authors:  E O Matechak; N Killeen; S M Hedrick; B J Fowlkes
Journal:  Immunity       Date:  1996-04       Impact factor: 31.745

6.  Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo.

Authors:  E R Kearney; K A Pape; D Y Loh; M K Jenkins
Journal:  Immunity       Date:  1994-07       Impact factor: 31.745

7.  Initial T cell frequency dictates memory CD8+ T cell lineage commitment.

Authors:  Amanda L Marzo; Kimberly D Klonowski; Agnes Le Bon; Persephone Borrow; David F Tough; Leo Lefrançois
Journal:  Nat Immunol       Date:  2005-07-17       Impact factor: 25.606

8.  High avidity antigen-specific CTL identified by CD8-independent tetramer staining.

Authors:  Ed Man-Lik Choi; Ji-Li Chen; Linda Wooldridge; Mariolina Salio; Anna Lissina; Nikolai Lissin; Ian F Hermans; Jonathan D Silk; Fareed Mirza; Michael J Palmowski; P Rod Dunbar; Bent K Jakobsen; Andy K Sewell; Vincenzo Cerundolo
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

9.  Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cells.

Authors:  Mikaël J Pittet; Verena Rubio-Godoy; Gilles Bioley; Philippe Guillaume; Pascal Batard; Daniel Speiser; Immanuel Luescher; Jean-Charles Cerottini; Pedro Romero; Alfred Zippelius
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

10.  Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers.

Authors:  M A Daniels; S C Jameson
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

View more
  10 in total

1.  Antigen-specific culture of memory-like CD8 T cells for adoptive immunotherapy.

Authors:  Adam J Litterman; David M Zellmer; Rebecca S LaRue; Stephen C Jameson; David A Largaespada
Journal:  Cancer Immunol Res       Date:  2014-05-22       Impact factor: 11.151

2.  Identification of Natural Regulatory T Cell Epitopes Reveals Convergence on a Dominant Autoantigen.

Authors:  John D Leonard; Dana C Gilmore; Thamotharampillai Dileepan; Wioletta I Nawrocka; Jaime L Chao; Mary H Schoenbach; Marc K Jenkins; Erin J Adams; Peter A Savage
Journal:  Immunity       Date:  2017-07-11       Impact factor: 31.745

3.  Characterization of a New Epitope of IRBP That Induces Moderate to Severe Uveoretinitis in Mice With H-2b Haplotype.

Authors:  Mary J Mattapallil; Phyllis B Silver; Lizette M Cortes; Anthony J St Leger; Yingyos Jittayasothorn; Jennifer L Kielczewski; James J Moon; Chi-Chao Chan; Rachel R Caspi
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-08       Impact factor: 4.799

4.  CD4+ T Cell Tolerance to Tissue-Restricted Self Antigens Is Mediated by Antigen-Specific Regulatory T Cells Rather Than Deletion.

Authors:  Francois P Legoux; Jong-Baeck Lim; Andrew W Cauley; Stanislav Dikiy; James Ertelt; Thomas J Mariani; Tim Sparwasser; Sing Sing Way; James J Moon
Journal:  Immunity       Date:  2015-11-10       Impact factor: 31.745

5.  Opposing peripheral fates of tissue-restricted self antigen-specific conventional and regulatory CD4+ T cells.

Authors:  Zimeng Zhang; Francois P Legoux; Spencer W Vaughan; James J Moon
Journal:  Eur J Immunol       Date:  2019-10-14       Impact factor: 5.532

6.  Allergic asthma is distinguished by sensitivity of allergen-specific CD4+ T cells and airway structural cells to type 2 inflammation.

Authors:  Josalyn L Cho; Morris F Ling; David C Adams; Lucas Faustino; Sabina A Islam; Roshi Afshar; Jason W Griffith; Robert S Harris; Aylwin Ng; Giorgia Radicioni; Amina A Ford; Andre K Han; Ramnik Xavier; William W Kwok; Richard Boucher; James J Moon; Daniel L Hamilos; Mehmet Kesimer; Melissa J Suter; Benjamin D Medoff; Andrew D Luster
Journal:  Sci Transl Med       Date:  2016-10-05       Impact factor: 19.319

7.  Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice.

Authors:  Yongli Zhang; Hangjie Zhang; Wenqiang Ma; Kefang Liu; Min Zhao; Yingze Zhao; Xuancheng Lu; Fuping Zhang; Xiangdong Li; George F Gao; William J Liu
Journal:  J Vis Exp       Date:  2018-10-17       Impact factor: 1.355

8.  Altered selection on a single self-ligand promotes susceptibility to organ-specific T cell infiltration.

Authors:  David E J Klawon; Dana C Gilmore; John D Leonard; Christine H Miller; Jaime L Chao; Matthew T Walker; Ryan K Duncombe; Kenneth S Tung; Erin J Adams; Peter A Savage
Journal:  J Exp Med       Date:  2021-06-07       Impact factor: 14.307

9.  Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination.

Authors:  Kirsten S Evonuk; Carson E Moseley; Ryan E Doyle; Casey T Weaver; Tara M DeSilva
Journal:  J Vis Exp       Date:  2016-09-12       Impact factor: 1.355

10.  VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance.

Authors:  Mohamed A ElTanbouly; Yanding Zhao; Elizabeth Nowak; Jiannan Li; Evelien Schaafsma; Isabelle Le Mercier; Sabrina Ceeraz; J Louise Lines; Changwei Peng; Catherine Carriere; Xin Huang; Maria Day; Brent Koehn; Sam W Lee; Milagros Silva Morales; Kristin A Hogquist; Stephen C Jameson; Daniel Mueller; Jay Rothstein; Bruce R Blazar; Chao Cheng; Randolph J Noelle
Journal:  Science       Date:  2020-01-17       Impact factor: 63.714

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.